Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53.5Revenue $M31.2Net Margin (%)100.0Altman Z-Score30.5
Enterprise Value $M18.7EPS $0.7Operating Margin %91.1Piotroski F-Score8
P/E(ttm)1.9Beneish M-Score--Pre-tax Margin (%)90.9Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio49.8Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %--Current Ratio49.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %5.6ROA % (ttm)98.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)106Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M44.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENZNCharles Brandes 2015-03-31 Add$0.95 - $1.23
($1.03)
$ 1.2117%Add 0.40%1,036,073
ENZNMichael Price 2014-12-31 Sold Out -0.05%$0.89 - $1.21
($1.05)
$ 1.2115%Sold Out0
ENZNMichael Price 2014-09-30 Reduce-0.05%$1.02 - $1.75
($1.25)
$ 1.21-3%Reduce 54.56%340,000
ENZNGeorge Soros 2014-09-30 Sold Out $1.02 - $1.75
($1.25)
$ 1.21-3%Sold Out0
ENZNGeorge Soros 2014-06-30 Buy $0.81 - $1.18
($0.95)
$ 1.2127%New holding50,123
ENZNSeth Klarman 2014-03-31 Sold Out -0.14%$0.861 - $1.26
($1.04)
$ 1.2116%Sold Out0
ENZNSeth Klarman 2013-12-31 Reduce-0.16%$1.15 - $1.74
($1.54)
$ 1.21-21%Reduce 43.60%4,337,858
ENZNCharles Brandes 2013-06-30 Add0.02%$1.6 - $3.95
($2.93)
$ 1.21-59%Add 184.52%1,026,723
ENZNCharles Brandes 2013-03-31 Add0.01%$3.79 - $4.99
($4.54)
$ 1.21-73%Add 432.17%360,865
ENZNFirst Eagle Investment 2012-12-31 Sold Out -0.01%$4.35 - $7
($6.03)
$ 1.21-80%Sold Out0
ENZNCharles Brandes 2012-12-31 Add$4.35 - $7
($6.03)
$ 1.21-80%Add 35.19%67,810
ENZNFirst Eagle Investment 2012-09-30 Reduce-0.02%$6.42 - $7.17
($6.8)
$ 1.21-82%Reduce 56.42%490,142
ENZNCharles Brandes 2012-06-30 Add$5.87 - $7.06
($6.44)
$ 1.21-81%Add 58.41%51,070
ENZNCharles Brandes 2012-03-31 Buy $6.54 - $7.82
($6.67)
$ 1.21-82%New holding32,240
ENZNCarl Icahn 2011-09-30 Add0.07%$7.24 - $10.37
($8.8)
$ 1.21-86%Add 25.00%5,904,863
ENZNGeorge Soros 2011-06-30 Sold Out $9.97 - $11.81
($10.79)
$ 1.21-89%Sold Out0
ENZNMichael Price 2011-03-31 Add0.16%$10.14 - $12.48
($11.15)
$ 1.21-89%Add 16.65%700,000
ENZNGeorge Soros 2011-03-31 Reduce$10.14 - $12.48
($11.15)
$ 1.21-89%Reduce 52.50%30,400
ENZNCarl Icahn 2010-12-31 Add0.41%$10.5 - $12.5
($11.36)
$ 1.21-89%Add 67.70%4,723,891
ENZNSeth Klarman 2010-09-30 Add0.14%$10.25 - $11.28
($10.74)
$ 1.21-89%Add 2.03%10,382,698
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENZN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-29.65view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-81.61view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-81.61view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-82.41view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-82.23view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-82.15view
Young Richard ADirector 2012-03-15Sell2,000$6.92-82.51view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-81.89view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-82.86view
LEBUHN ROBERTDirector 2011-06-01Sell8,702$10.57-88.55view

Quarterly/Annual Reports about ENZN:

News about ENZN:

Articles On GuruFocus.com
Top Micro-Cap Picks From the Gurus Jun 23 2015 
icahn May 27 2015 
Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
GuruFocus Real Time Picks of the Week Jan 10 2014 
Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
First Pacific Advisors’ Top New Buys Aug 08 2012 
Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 
Carl Icahn Buys NAV, CHK, ENZN, AMLN, CMC, Feb 15 2011 

More From Other Websites
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jul 02 2015
ENZON PHARMACEUTICALS INC Financials May 22 2015
10-Q for Enzon Pharmaceuticals, Inc. May 15 2015
ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 13 2015
Nasdaq stocks posting largest volume increases Apr 29 2015
Most active Nasdaq-traded stocks Apr 29 2015
Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot Apr 01 2015
ENZON PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 05 2015
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 10 2014
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 05 2014
ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent Nov 03 2014
Bankruptcy Filing Fallout Continues For NII Holdings Sep 19 2014
ENZON PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
Enzon regains compliance with Nasdaq Jul 16 2014
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 16 2014
Enzon Pharmaceuticals Inc Stock Upgraded (ENZN) Jul 08 2014
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jun 12 2014
ENZON PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... May 30 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

BasseyeNet@twitter
ReplyBasseyeNet@twitter - 10 months ago
Tangible Book Value:

$ 0.47 Add to Fair Value


Growth Value:$ 5.53


Terminal Value: $ 3.47


= Fair Value: $ 9
BasseyeNet@twitter
ReplyBasseyeNet@twitter - 10 months ago
George Soros (Trades, Portfolio) just joined Carl Icahn (Trades, Portfolio) 2 months ago by adding ENZN to his portfolio...The 1yr price target is $14 on Yahoo finance.. Link below is a breakdown of the Billionaire's holding and adding to there positions in this company.

http://www.gurufocus.com/gurutrades/ENZN#hold
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK